NYSE:FMS - Fresenius Medical Care AG & Co. Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$37.53 -1.48 (-3.79 %)
(As of 11/20/2018 04:00 PM ET)
Previous Close$39.01
Today's Range$37.47 - $38.08
52-Week Range$37.47 - $57.94
Volume228,001 shs
Average Volume161,530 shs
Market Capitalization$24.61 billion
P/E Ratio16.98
Dividend Yield1.06%
Beta1.1
Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure. The company's products include dialysis machines, dialyzers and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis. Fresenius Medical Care was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:FMS
Previous Symbol
CUSIPN/A
Phone49-6172-6090

Debt

Debt-to-Equity Ratio0.41
Current Ratio1.24
Quick Ratio1.00

Price-To-Earnings

Trailing P/E Ratio16.98
Forward P/E Ratio14.89
P/E Growth1.78

Sales & Book Value

Annual Sales$20.09 billion
Price / Sales1.14
Cash Flow$3.3419 per share
Price / Cash11.23
Book Value$19.97 per share
Price / Book1.88

Profitability

EPS (Most Recent Fiscal Year)$2.21
Net Income$1.45 billion
Net Margins11.71%
Return on Equity10.87%
Return on Assets5.07%

Miscellaneous

Employees114,000
Outstanding Shares612,900,000
Market Cap$24.61 billion
OptionableOptionable

Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. announced an annual dividend on Thursday, May 10th. Investors of record on Tuesday, May 22nd will be given a dividend of $0.436 per share on Monday, June 4th. This represents a yield of 0.86%. The ex-dividend date of this dividend is Monday, May 21st. View Fresenius Medical Care AG & Co.'s Dividend History.

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) released its quarterly earnings data on Tuesday, October, 30th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.58 by $0.11. The business earned $4.72 billion during the quarter. Fresenius Medical Care AG & Co. had a net margin of 11.71% and a return on equity of 10.87%. View Fresenius Medical Care AG & Co.'s Earnings History.

When is Fresenius Medical Care AG & Co.'s next earnings date?

Fresenius Medical Care AG & Co. is scheduled to release their next quarterly earnings announcement on Monday, February 25th 2019. View Earnings Estimates for Fresenius Medical Care AG & Co..

What price target have analysts set for FMS?

10 Wall Street analysts have issued 1-year price objectives for Fresenius Medical Care AG & Co.'s shares. Their predictions range from $46.00 to $82.00. On average, they anticipate Fresenius Medical Care AG & Co.'s stock price to reach $64.00 in the next twelve months. This suggests a possible upside of 70.5% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co..

What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co.?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co..

Has Fresenius Medical Care AG & Co. been receiving favorable news coverage?

Headlines about FMS stock have trended somewhat positive recently, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an impact on the company's share price in the near term.

Are investors shorting Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. saw a drop in short interest during the month of October. As of October 31st, there was short interest totalling 297,169 shares, a drop of 48.6% from the October 15th total of 578,575 shares. Based on an average trading volume of 328,173 shares, the days-to-cover ratio is presently 0.9 days. View Fresenius Medical Care AG & Co.'s Current Options Chain.

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the folowing people:
  • Rice Powell, Chief Executive Officer
  • Michael Brosnan, Chief Financial Officer
  • Olaf Schermeier, CEO-Global Research & Development
  • Kent Wanzek, CEO-Global Manufacturing & Quality
  • Harry de Wit, Chief Executive Officer-Asia Pacific

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by many different of retail and institutional investors. Top institutional investors include Thornburg Investment Management Inc. (0.08%), US Bancorp DE (0.05%), Wells Fargo & Company MN (0.04%), Aperio Group LLC (0.04%), Franklin Resources Inc. (0.03%) and Ferguson Wellman Capital Management Inc. (0.02%).

Which major investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Renaissance Technologies LLC, Russell Investments Group Ltd., Aperio Group LLC, Bank of New York Mellon Corp, BB&T Corp, Dean Capital Investments Management LLC and Atlas Capital Advisors LLC.

Which major investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was bought by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Franklin Resources Inc., Thornburg Investment Management Inc., Jane Street Group LLC, Fulton Bank N.A., US Bancorp DE, Crossmark Global Holdings Inc. and Atria Investments LLC.

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $37.53.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $24.61 billion and generates $20.09 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $2.21 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 114,000 workers across the globe.

What is Fresenius Medical Care AG & Co.'s official website?

The official website for Fresenius Medical Care AG & Co. is http://www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-6090 or via email at [email protected]


MarketBeat Community Rating for Fresenius Medical Care AG & Co. (NYSE FMS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  381 (Vote Underperform)
Total Votes:  637
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel